Article metrics

Download PDFPDF
Efficacy and Safety of AEZS-108 (LHRH Agonist Linked to Doxorubicin) in Women With Advanced or Recurrent Endometrial Cancer Expressing LHRH Receptors: A Multicenter Phase 2 Trial (AGO-GYN5)

 

Online download statistics by month:

Online download statistics by month: February 2019 to September 2022

AbstractFullPdf
Feb 2019600
Mar 20194404
Apr 20198100
May 20195500
Jun 20194600
Jul 20196401
Aug 20194900
Sep 20194000
Oct 20193002
Nov 20193601
Dec 20193400
Jan 20207002
Feb 20202300
Mar 20202200
Apr 20203300
May 20203400
Jun 20203000
Jul 20203600
Aug 20201600
Sep 20202700
Oct 20201000
Nov 20201200
Dec 20201700
Jan 20211400
Feb 20212500
Mar 20212801
Apr 2021600
May 20213001
Jul 2021200
Aug 2021100
Oct 20212600
Nov 20212500
Dec 20211600
Jan 20225604
Feb 20221002
Mar 20223200
Apr 20223701
May 20224900
Jun 20227101
Jul 20223201
Aug 20225403
Sep 20226601
Total1395025